Cargando…
Perspectives on development of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
The recent outbreak of Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been characterized by the World Health Organization (WHO) as a controllable global pandemic. The spike (S) glycoprotein mediates binding to the angiotensin-...
Autores principales: | Zhang, Chao, Zhou, Chenliang, Shi, Li, Liu, Ge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644209/ https://www.ncbi.nlm.nih.gov/pubmed/32961082 http://dx.doi.org/10.1080/21645515.2020.1787064 |
Ejemplares similares
-
A comparative review of pathogenesis and host innate immunity evasion strategies among the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV)
por: Noor, Rashed
Publicado: (2021) -
Relative Sensitivity of Saliva and Upper Airway Swabs for Initial Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Ambulatory Patients: Rapid Review
por: O'Leary, Timothy J.
Publicado: (2021) -
Respiratory delivery of passive immunotherapies for SARS-CoV-2 prophylaxis and therapy
por: Focosi, Daniele, et al.
Publicado: (2023) -
Prospects for mucosal vaccine: shutting the door on SARS-CoV-2
por: Mudgal, Rajat, et al.
Publicado: (2020) -
Severe acute respiratory syndrome coronavirus 2 variants–Possibility of universal vaccine design: A review
por: Yoon, Eunhye, et al.
Publicado: (2022)